CYLD cutaneous syndrome

From WikiMD's Wellness Encyclopedia

CYLD cutaneous syndrome
[[File:|250px|]]
Synonyms N/A
Pronounce N/A
Specialty N/A
Symptoms Skin tumors, cylindromas, trichoepitheliomas, spiradenomas
Complications Malignant transformation
Onset Childhood or early adulthood
Duration Lifelong
Types N/A
Causes Genetic mutation in the CYLD gene
Risks Family history
Diagnosis Clinical examination, genetic testing
Differential diagnosis N/A
Prevention N/A
Treatment Surgical removal, laser therapy
Medication N/A
Prognosis Variable, depending on tumor burden and management
Frequency N/A
Deaths N/A


CYLD cutaneous syndrome is a rare genetic disorder characterized by the development of multiple skin tumors, primarily cylindromas, trichoepitheliomas, and spiradenomas. These tumors are generally benign but can cause significant cosmetic and functional issues. In some cases, there is a risk of malignant transformation.

Genetics[edit | edit source]

CYLD cutaneous syndrome is caused by mutations in the CYLD gene, which is located on chromosome 16q12.1. The CYLD gene encodes a protein that acts as a tumor suppressor by regulating cell proliferation and apoptosis. Mutations in this gene lead to uncontrolled cell growth, resulting in the formation of skin tumors.

Clinical Features[edit | edit source]

Patients with CYLD cutaneous syndrome typically present with multiple skin lesions that appear in childhood or early adulthood. The most common types of tumors include:

  • Cylindromas: Dome-shaped nodules that often occur on the scalp and can coalesce to form a "turban tumor."
  • Trichoepitheliomas: Small, flesh-colored papules that usually appear on the face.
  • Spiradenomas: Painful nodules that can occur anywhere on the body.

Diagnosis[edit | edit source]

Diagnosis of CYLD cutaneous syndrome is based on clinical examination and family history. Genetic testing can confirm the presence of mutations in the CYLD gene. Histopathological examination of the tumors can also aid in diagnosis.

Management[edit | edit source]

Management of CYLD cutaneous syndrome involves regular monitoring and surgical removal of symptomatic or cosmetically concerning tumors. Laser therapy may be used for smaller lesions. In cases where there is a risk of malignant transformation, more aggressive treatment may be necessary.

Prognosis[edit | edit source]

The prognosis for individuals with CYLD cutaneous syndrome varies. While the tumors are generally benign, they can cause significant cosmetic and psychological distress. Regular follow-up and management are essential to prevent complications.

Also see[edit | edit source]

CYLD cutaneous syndrome Resources
Wikipedia
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD